-
Analyst Opinions
NewNew Prescription – Generative AI Meets Healthcare (Vol. 2)
Generative Artificial Intelligence (AI) in Healthcare Report Overview GenAI is generating considerable buzz within the healthcare sector, from news updates to deal negotiations and company filings primarily to drive down costs and optimize administrative workflows, promising better healthcare. From accelerating R&D to easing administrative tasks and creating personalized patient experiences, genAI innovations have now proliferated across all the major healthcare application areas. The ’Generative Artificial Intelligence (AI) in Healthcare’ research report is a compendium of the latest real-world innovations in...
-
Company Insights
Sanofi S.A – Digital Transformation Strategies
Sanofi Digital Transformation Strategies Report Overview Sanofi S.A. (Sanofi) has been focusing on using artificial intelligence, cloud, virtual reality and big data to digitally transform its operations. The annual ICT spending of Sanofi was estimated at $1.1 billion for 2023. A major share of this spending is earmarked for acquiring software, ICT services and consulting services from vendors. Sanofi is a France-based multinational life sciences company. It focuses on the research & development, manufacture, and marketing of a wide range...
-
Company Profile
Owkin Inc – Company Profile
Owkin Inc (Owkin) is a life science technology company that offers artificial intelligence and machine learning solutions for developing medicines, discovering new treatments, drugs and disease remedies. The company’s services include biomarker engine, drug discovery, clinical development and diagnostics. It develops federated learning solutions for medical research activities. The company utilizes MSIntuit CRC, a CE-marked artificial intelligence (AI) diagnostic, that optimizes microsatellite instability (MSI) testing for colorectal cancer and and RlapsRisk BC that helps in the treatment for early breast...
Add to Basket -
Thematic Analysis
Artificial Intelligence (AI) in Drug Discovery Market – Thematic Research
Explore trends and insights from the following data in the ‘Artificial Intelligence (AI) in Drug Discovery Market’ thematic report: Understanding the key trends impacting the theme over the next 12 to 24 months. Comprehensive analysis of drugs discovered using AI and survey data on the adoption of AI in pharma. Detailed value chain breaks down Artificial Intelligence (AI) in the Drug Discovery Market into Target Identification and Validation, Generation of Molecule Leads/De Novo Drug Design, Drug Repurposing, and Response Biomarker...
-
Thematic Analysis
Big Data in Pharmaceuticals – Thematic Research
The global data and analytics market in the pharma sector was valued at $1.4 billion in 2020. The healthcare and pharmaceutical industries generate data in abundance from a multitude of sources including physician notes, pathology reports, electronic health records (EHR), patient registries, genomics, clinical trials, social media, wearable devices, and many more. The dataset in question is huge in both size and complexity, rendering traditional data management techniques inefficient for processing. This big data in pharmaceuticals - thematic research report...
-
Sector Analysis
Spain In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others.
GlobalData’s “Spain In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Spain In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The Spain In Vitro Diagnostics Market report provides key information and data on: • Annualized market revenues (USD), volume...
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...